In order to explore the potential of IL20RB in enhancing the stemness of pancreatic cancer cells, we constructed stable cell lines, including MIA PaCa-2 with IL20RB overexpression and PANC-1 with IL20RB knockdown (Fig. 2A–B). This evidence concerns the gene IL20RB and familial pancreatic carcinoma.